Quinolone Resistant Escherichia coli at a Cancer Center
Quinolone Resistant Escherichia coli at a Cancer Center, Lead author: Rolston KV, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA
Evaluation of Susceptibility Patterns of Klebsiella spp. Isolated in Latin America. Results of the SENTRY Antimicrobial Surveillance Program (1997-2006)
Evaluation of Susceptibility Patterns of Klebsiella spp. Isolated in Latin America. Results of the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA
Antimicrobial Susceptibility of Pseudomonas aeruginosa (PSA) Causing Bloodstream Infections (BSI) in Brazilian Medical Centers: Results of the SENTRY Antimicrobial Surveillance Program (2001-2006)
Antimicrobial Susceptibility of Pseudomonas aeruginosa (PSA) Causing Bloodstream Infections (BSI) in Brazilian Medical Centers: Results of the SENTRY Antimicrobial Surveillance Program (2001-2006), Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA
Metallo-ß-Lactamases Genes, blaIMP-15 and blaIMP-18 in a Class 1 Integrons form Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico
Metallo-ß-Lactamases Genes, blaIMP-15 and blaIMP-18 in a Class 1 Integrons form Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico, Lead author: Garza-Ramos U, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA
Spectrum and Potency of Tigecycline Tested Against Non-Fermentative Gram-negative Bacilli (NFGN) Collected in Across the Asia-Pacific Region (2006)
Spectrum and Potency of Tigecycline Tested Against Non-Fermentative Gram-negative Bacilli (NFGN) Collected in Across the Asia-Pacific Region (2006), Lead author: Sader HS, presented at 45th annual Infectious Diseases Society of America (IDSA), October 4 – 7, 2007, San Diego, CA
In vitro Comparison of Vancomycin, Ceftobiprole, and Linezolid in a Pharmacodynamic Model Against Methicillin-Resistant Staphylococcus aureus including wild type, heteroresistant, tolerant, and CA-MRSA strains
In vitro Comparison of Vancomycin, Ceftobiprole, and Linezolid in a Pharmacodynamic Model Against Methicillin-Resistant Staphylococcus aureus including wild type, heteroresistant, tolerant, and CA-MRSA strains, Lead author: Schafer J, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Use of Pharmacokinetics-Pharmacodynamics (PK-PD) and Monte Carlo Simulations (MCS) as Decision Support for Determination of Penicillin VK (PEN V) Susceptibility Breakpoints for Streptococcus pneumoniae (SP)
Use of Pharmacokinetics-Pharmacodynamics (PK-PD) and Monte Carlo Simulations (MCS) as Decision Support for Determination of Penicillin VK (PEN V) Susceptibility Breakpoints for Streptococcus pneumoniae (SP), Lead author: Forrest A, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Association of blaSPM-1 with the Transposon Tn4371
Association of blaSPM-1 with the Transposon Tn4371, Lead author: Castanheira M, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Dissemination and Genetic Context Analysis of blaVIM-6 among Psuedomonas aeruginosa in Asia-Pacific Nations
Dissemination and Genetic Context Analysis of blaVIM-6 among Psuedomonas aeruginosa in Asia-Pacific Nations, Lead author: Castanheira M, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Genetic and Functional Analysis of ISCR4 Indicates that ISCR4 and blaSPM-1 are Fused in the SPM-1-Carrying Plasmids
Genetic and Functional Analysis of ISCR4 Indicates that ISCR4 and blaSPM-1 are Fused in the SPM-1-Carrying Plasmids, Lead author: Castanheira M, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
The Combination of ISCR2 and floR Represent a Unique Co-Dependant Transposable Structure
The Combination of ISCR2 and floR Represent a Unique Co-Dependant Transposable Structure, Lead author: Toleman MA, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Antimicrobial Activity of Telavancin Against Contemporary Enterococci and Streptococci: Initial Results from a Global Surveillance Program (2007)
Antimicrobial Activity of Telavancin Against Contemporary Enterococci and Streptococci: Initial Results from a Global Surveillance Program (2007), Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
GES-Producing Pseudomonas aeruginosa (PSA): Prevalence, Genetic Relatedness and Analysis of the blaGES Genetic Context
GES-Producing Pseudomonas aeruginosa (PSA): Prevalence, Genetic Relatedness and Analysis of the blaGES Genetic Context, Lead author: Picao, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Emergence and Widespread Dissemination of OXA-23, -24 and -58 Carbapenemases Among Acinetobacter spp. in Asia-Pacific Nations (APAC): Report from the SENTRY Antimicrobial Surveillance Program (2006)
Emergence and Widespread Dissemination of OXA-23, -24 and -58 Carbapenemases Among Acinetobacter spp. in Asia-Pacific Nations (APAC): Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
10 Years of Surveillance of Bloodstream Infections (BSI) in North American (NA) Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006)
10 Years of Surveillance of Bloodstream Infections (BSI) in North American (NA) Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Detection of Methyltransferases (MT) Conferring High-Level Resistance (R) to Aminoglycosides (AG) in Enterobacteriaceae (ENT) from Europe, North America and Latin America
Detection of Methyltransferases (MT) Conferring High-Level Resistance (R) to Aminoglycosides (AG) in Enterobacteriaceae (ENT) from Europe, North America and Latin America, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Enterobacter spp. in the Asia-Pacific (APAC) Region: A SENTRY Antimicrobial Surveillance Program Report (2006)
Enterobacter spp. in the Asia-Pacific (APAC) Region: A SENTRY Antimicrobial Surveillance Program Report (2006), Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Dissemination of IMP-Type Metallo-β-Lactamases among Pseudomonas aeruginosa and Emergence of VIM-2 in Klebsiella oxytoca in Mexico: Report from the SENTRY Antimicrobial Surveillance Program
Dissemination of IMP-Type Metallo-β-Lactamases among Pseudomonas aeruginosa and Emergence of VIM-2 in Klebsiella oxytoca in Mexico: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Initial Occurrences of Linezolid (LZD) Resistance (R) from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program (Europe, Latin, America, Asia Pacific)
Initial Occurrences of Linezolid (LZD) Resistance (R) from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program (Europe, Latin, America, Asia Pacific), Lead author: Ross JE, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
To Split, or Not to Split a MIC Distribution, That is the Question: Setting Susceptibility Breakpoints
To Split, or Not to Split a MIC Distribution, That is the Question: Setting Susceptibility Breakpoints, Lead author: Bhavnani SM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Detection of Antimicrobial Susceptibility Testing (AST) Errors by Automated Systems: College of American Pathologists (CAP) Microbiology Surveys Results for 2003-2006
Detection of Antimicrobial Susceptibility Testing (AST) Errors by Automated Systems: College of American Pathologists (CAP) Microbiology Surveys Results for 2003-2006, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Critical Evaluation of Linezolid Susceptibility (S) Testing Using Two Automated Systems (Vitek, Vitek 2)
Critical Evaluation of Linezolid Susceptibility (S) Testing Using Two Automated Systems (Vitek, Vitek 2), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Intermethod Comparability Analyses of Tigecycline Antimicrobial Susceptibility Tests (AST) Using over 5,000 Pathogens Isolated in Asia-Pacific Countries
Intermethod Comparability Analyses of Tigecycline Antimicrobial Susceptibility Tests (AST) Using over 5,000 Pathogens Isolated in Asia-Pacific Countries, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Proposed Disk Diffusion (DD) Quality Control (QC) Ranges for Ulifloxacin (ULI) and Intermethod Comparison Using CLSI Broth Microdilution and DD
Proposed Disk Diffusion (DD) Quality Control (QC) Ranges for Ulifloxacin (ULI) and Intermethod Comparison Using CLSI Broth Microdilution and DD, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Selection of a Surrogate Carbapenem (CARB) Testing Agent for Initial Susceptibility (S) Testing of Doripenem (DOR)
Selection of a Surrogate Carbapenem (CARB) Testing Agent for Initial Susceptibility (S) Testing of Doripenem (DOR), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Re-Evaluations of H. influenzae (HI) Susceptibility (S) Tests for Penicillins ± β-Lactamase Inhibitors against β-Lactamase-Negative Ampicillin-Resistant (BLNAR) Strains: a SENTRY Program Report
Re-Evaluations of H. influenzae (HI) Susceptibility (S) Tests for Penicillins ± β-Lactamase Inhibitors against β-Lactamase-Negative Ampicillin-Resistant (BLNAR) Strains: a SENTRY Program Report, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
In Vitro Evaluation of TD-1792; a Novel Antimicrobic with Potent Gram-Positive Activity
In Vitro Evaluation of TD-1792; a Novel Antimicrobic with Potent Gram-Positive Activity, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
In Vitro Activity of Ulifloxacin Tested against a Worldwide Collection of Pathogens Producing Traveler’s Diarrhea
In Vitro Activity of Ulifloxacin Tested against a Worldwide Collection of Pathogens Producing Traveler’s Diarrhea, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Antimicrobial Activity of Omiganan Pentahydrochloride against Contemporary (2005-2006) Gram-Negative Pathogens Responsible for Local Catheter Site Infections
Antimicrobial Activity of Omiganan Pentahydrochloride against Contemporary (2005-2006) Gram-Negative Pathogens Responsible for Local Catheter Site Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Activity of Omiganan against Contemporary (2005-2006) Gram-Positive Pathogens Responsible for Catheter Colonization and Catheter-Related Bloodstream Infections
Activity of Omiganan against Contemporary (2005-2006) Gram-Positive Pathogens Responsible for Catheter Colonization and Catheter-Related Bloodstream Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Doripenem Activity Tested Against Gram-Negative Pathogens in the Asia-Pacific (APAC) Region: Report from the SENTRY Antimicrobial Surveillance Program, 2006
Doripenem Activity Tested Against Gram-Negative Pathogens in the Asia-Pacific (APAC) Region: Report from the SENTRY Antimicrobial Surveillance Program, 2006, Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Antimicrobial Activity of PZ-601 (SMP-601) Tested against Selected Wildtype (WT) and Resistant (R) Collection of Targeted Species (U.S. and Europe)
Antimicrobial Activity of PZ-601 (SMP-601) Tested against Selected Wildtype (WT) and Resistant (R) Collection of Targeted Species (U.S. and Europe), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Activity of Ceftobiprole (BPR) Tested against Gram-Positive and -Negative Pathogens in the Asia-Pacific Region: Report from the SENTRY Antimicrobial Surveillance Program (2006)
Activity of Ceftobiprole (BPR) Tested against Gram-Positive and -Negative Pathogens in the Asia-Pacific Region: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Bell JM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Antimicrobial Activity of ME1036 and Ceftaroline Tested against Clinical Strains of Community-Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA)
Antimicrobial Activity of ME1036 and Ceftaroline Tested against Clinical Strains of Community-Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Activity of Tigecycline (TGC) Tested against Clinical Pathogens Collected in Korea, the Philippines, Singapore and Thailand (2006)
Activity of Tigecycline (TGC) Tested against Clinical Pathogens Collected in Korea, the Philippines, Singapore and Thailand (2006), Lead author: Bell JM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Antimicrobial Activity of Iclaprim Tested against Recent Staphylococcus aureus Clinical Isolates: Results from the International Study of Iclaprim Susceptility (ISIS)
Antimicrobial Activity of Iclaprim Tested against Recent Staphylococcus aureus Clinical Isolates: Results from the International Study of Iclaprim Susceptility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
In Vitro Activity of Iclaprim and Comparison Agents Tested against Neisseria gonorrhoeae Including Growth Stimulating Effects
In Vitro Activity of Iclaprim and Comparison Agents Tested against Neisseria gonorrhoeae Including Growth Stimulating Effects, Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Antimicrobial Activity of a Novel Dihydrofolate Reductase, Iclaprim, Tested against Clinical Strains of Enterobacteriaceae (ENT): Results from the International Study of Iclaprim Susceptibility (ISIS)
Antimicrobial Activity of a Novel Dihydrofolate Reductase, Iclaprim, Tested against Clinical Strains of Enterobacteriaceae (ENT): Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Comparative Evaluation of Iclaprim Potency and Bactericidal Activity Tested against Enterococci: Results from the International Study of Iclaprim Susceptibility (ISIS)
Comparative Evaluation of Iclaprim Potency and Bactericidal Activity Tested against Enterococci: Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against ß-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS).
In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against ß-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS)., Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Evaluation of the Novel Ceragenin, CSA-13 Activity and Potential Synergy (SYN) against Clinical Isolates of Pseudomonas aeruginosa (PA), Including Multi-Drug Resistant PA (MDR-PA)
Evaluation of the Novel Ceragenin, CSA-13 Activity and Potential Synergy (SYN) against Clinical Isolates of Pseudomonas aeruginosa (PA), Including Multi-Drug Resistant PA (MDR-PA), Lead author: Chin JN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Discovery of EP-014887: A Novel Oxime 3,6-Bicyclolide with High Potency against MRSA and a Favorable In Vivo Efficacy Profile
Discovery of EP-014887: A Novel Oxime 3,6-Bicyclolide with High Potency against MRSA and a Favorable In Vivo Efficacy Profile, Lead author: Tang D, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Activity of Omiganan Pentahydrochloride against Yeast and Mould Pathogens Associated with Catheter Colonization and Catheter-Related Bloodstream Infections
Activity of Omiganan Pentahydrochloride against Yeast and Mould Pathogens Associated with Catheter Colonization and Catheter-Related Bloodstream Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL
Differential Potential for the Disinfectant Benzalkonium Chloride and the Antiseptics Chlorhexidine and Omiganan Pentahydrochloride to Serve as Resistance Selectors in the Hospital Environment
Differential Potential for the Disinfectant Benzalkonium Chloride and the Antiseptics Chlorhexidine and Omiganan Pentahydrochloride to Serve as Resistance Selectors in the Hospital Environment, Lead author: Johnson DM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada
A Multi-Site Comparison Study of the Sensititre Automated/Manual Susceptibility Plate to the CLSI Microdilution Method for Streptococcus spp.
A Multi-Site Comparison Study of the Sensititre Automated/Manual Susceptibility Plate to the CLSI Microdilution Method for Streptococcus spp., Lead author: Killian SB, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada
A Multi-Site Study of a Broth D Zone Test System Using TREK Sensititre® 18-24 hour dried Susceptibility Plates for Detecting Inducible Resistance to Clindamycin in Macrolide Resistant Gram-Positive Organisms
A Multi-Site Study of a Broth D Zone Test System Using TREK Sensititre® 18-24 hour dried Susceptibility Plates for Detecting Inducible Resistance to Clindamycin in Macrolide Resistant Gram-Positive Organisms, Lead author: Miskov AM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada
Dalbavancin Disk Diffusion Tests: Development Evaluations Using Various Disk Concentrations, Solvents and Surfactants
Dalbavancin Disk Diffusion Tests: Development Evaluations Using Various Disk Concentrations, Solvents and Surfactants, Lead author: Jones RN, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada
Comparative Results of Oxacillin and Cefoxitin Disk Diffusion Staphylococcal Tests and the Occurrence of Inducible Clindamycin Resistance in Various Gram-Positive Species: Results from a 52-Center Trial of a Novel Lipopeptide
Comparative Results of Oxacillin and Cefoxitin Disk Diffusion Staphylococcal Tests and the Occurrence of Inducible Clindamycin Resistance in Various Gram-Positive Species: Results from a 52-Center Trial of a Novel Lipopeptide, Lead author: Biedenbach DJ, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada
Re-Evaluation of Disk Diffusion Breakpoints for Tigecycline When Testing Enterobacteriaceae
Re-Evaluation of Disk Diffusion Breakpoints for Tigecycline When Testing Enterobacteriaceae, Lead author: Sader HS, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada
Feasibility Studies for Anidulafungin Disk Diffusion Susceptibility Testing of Yeast by CLSI M-44 Method
Feasibility Studies for Anidulafungin Disk Diffusion Susceptibility Testing of Yeast by CLSI M-44 Method, Lead author: Rhomberg PR, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada